Lee Sang-hoon
$1.5B
Born
Jan 01, 1963
Age
62
Source of Wealth
Biotech
Residence
Seoul,
Citizenship
United States
Marital Status
Married
Children
1
Education
Ph.D, Ohio State University; Bachelor of Science, Seoul National University; Master of Science, Seoul National University
- Lee Sang-hoon is the founder, chairman, CEO and chief research officer of South Korean biotechnology company ABL Bio.
- ABL Bio develops bispecific antibodies, which target two molecules simultaneously to improve treatment outcomes for cancer and neurodegenerative diseases.
- In November 2025, it signed a $2.6 billion technology-transfer deal with Eli Lilly related to ABL Bio's Grabody-B blood-brain-barrier-penetrating bispecific antibody technology.
- Lee founded ABL Bio in 2016 and listed it on Korea's Kosdaq stock exchange two years later.
| Exchange | Ticker | Company Name | Number Of Shares | Share Price | Currency Code |
|---|